Literature DB >> 16521094

Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size.

Waqar Rashid1, Gerard R Davies, Declan T Chard, Colette M Griffin, Dan R Altmann, Ros Gordon, Raju Kapoor, Alan J Thompson, David H Miller.   

Abstract

PURPOSE: To determine whether the upper cervical cord area (UCCA) is influenced by disease effect in early relapsing-remitting multiple sclerosis (MS), using statistical modeling to account for potential covariates.
MATERIALS AND METHODS: A cohort of 39 patients were studied cross-sectionally within three years of first symptom onset (median disease duration = 1.6 years) and compared with 26 healthy controls. The UCCA was measured from axial reconstructions of three-dimensional T1-weighted scans with automated detection of the edge of the cord. Statistical analysis adjusted for factors such as total intracranial volume (TICV) and gender. Clinical correlations, in particular those thought likely to be related to cord pathology, were also investigated.
RESULTS: No significant disease effect was noted on UCCA (P = 0.685), although there was borderline evidence of a lower UCCA in patients with symptoms of bowel or bladder disturbance (P = 0.043). A strong association was noted between UCCA and TICV (r = 0.558; P < or = 0.001), and there was a trend for females to have a smaller UCCA (P = 0.062). The latter finding appeared to reflect a gender-related difference in TICV (P < or = 0.001).
CONCLUSION: Atrophy of the upper cervical cord is not readily apparent in most patients early in the course of relapsing-remitting MS. In evaluations of disease-related changes in the UCCA in cross-sectional studies, TICV and gender should be considered as potentially confounding covariates. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16521094     DOI: 10.1002/jmri.20545

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Brain size and white matter content of cerebrospinal tracts determine the upper cervical cord area: evidence from structural brain MRI.

Authors:  Christina Engl; Paul Schmidt; Milan Arsic; Christine C Boucard; Viola Biberacher; Michael Röttinger; Thorleif Etgen; Sabine Nunnemann; Nikolaos Koutsouleris; Maximilian Reiser; Eva M Meisenzahl; Mark Mühlau
Journal:  Neuroradiology       Date:  2013-05-29       Impact factor: 2.804

Review 2.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

3.  Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.

Authors:  Nico Papinutto; Carlo Asteggiano; Antje Bischof; Tristan J Gundel; Eduardo Caverzasi; William A Stern; Stefano Bastianello; Stephen L Hauser; Roland G Henry
Journal:  J Neuroimaging       Date:  2019-09-30       Impact factor: 2.486

4.  MRI Measurement of Upper Cervical Spinal Cord Cross-Sectional Area in Children.

Authors:  Nico Papinutto; Christian Cordano; Carlo Asteggiano; Eduardo Caverzasi; Maria Luisa Mandelli; Michael Lauricella; Nicole Yabut; Matthew Neylan; Gina Kirkish; Maria Luisa Gorno-Tempini; Roland G Henry
Journal:  J Neuroimaging       Date:  2020-07-08       Impact factor: 2.486

5.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

6.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

7.  State of the cervical section of the spinal cord in patients with remitting multiple sclerosis during immunomodulatory treatment.

Authors:  E G Shipova; N N Spirin; D S Kasatkin; E I Shumakov; I O Stepanov
Journal:  Neurosci Behav Physiol       Date:  2009-01

8.  Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.

Authors:  Mark A Horsfield; Stefania Sala; Mohit Neema; Martina Absinta; Anshika Bakshi; Maria Pia Sormani; Maria A Rocca; Rohit Bakshi; Massimo Filippi
Journal:  Neuroimage       Date:  2010-01-07       Impact factor: 6.556

9.  Spinal cord normalization in multiple sclerosis.

Authors:  Jiwon Oh; Michaela Seigo; Shiv Saidha; Elias Sotirchos; Kathy Zackowski; Min Chen; Jerry Prince; Marie Diener-West; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2014-03-05       Impact factor: 2.486

10.  Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis.

Authors:  Z Liptak; A M Berger; M P Sampat; A Charil; O Felsovalyi; B C Healy; P Hildenbrand; S J Khoury; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-12       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.